Showing results 13 to 19 of 19
< previous
| Title | Author(s) | Issue Date | |
|---|---|---|---|
| 2021 | |||
Salvage Therapy Beyond Targeted Therapy in Lung Adenocarcinoma Journal:Seminars in Respiratory and Critical Care Medicine | 2013 | ||
Serum protein level as a predictor of therapeutic response and adverse effects associated with afatinib use Journal:Journal of Thoracic Disease | 2022 | ||
| 2022 | |||
Territory-wide study on hospital admissions for asthma exacerbations in the COVID-19 pandemic Journal:Annals of the American Thoracic Society | 2021 | ||
| 2012 | |||
When compared to plasma-based detection, osimertinib-treated non-small cell lung cancer (NSCLC) with tissue rebiopsy-confirmed acquired T790M mutation is associated with better survival Journal:Asia-Pacific Journal of Clinical Oncology | 2021 |